西班牙多发性硬化症的流行情况. 来自初级保健临床数据库 (BDCAP) 的估计
L Cayuela1, C García-Muñoz2, S Sainz de la Maza3
1Department of Internal Medicine, Hospital Severo Ochoa, Leganés, Spain.
Neurologia
|June 16, 2025
概括
这项研究揭示了西班牙多发性硬化症 (MS) 的最新流行情况,估计有61,753例,自主社区 (AC) 的流行率具有显著的南北地理梯度. 这些发现对于未来的MS管理策略至关重要.
科学领域:
- 流行病学 流行病学
- 神经学 神经学
背景情况:
- 全球多发性硬化症 (MS) 患病率上升,需要更新西班牙的流行病学数据.
- 之前在西班牙的MS流行数据需要最近的更新,以告知公共卫生战略.
研究的目的:
- 用2021年的数据确定西班牙多发性硬化症 (MS) 的流行率.
- 分析和比较2021年不同自治社区 (AC) 的MS患病率,按性别划分.
- 为了确定在西班牙的MS患病率的地理模式.
主要方法:
- 一项利用2021年多发性硬化患者数据的初级保健临床数据库 (BDCAP) 的横截面研究.
- 计算每10万人/年的原始和年龄标准化患病率.
- 使用标准化流行率和相对风险 (RR) 估计器进行地理分析,以确定区域差异.
主要成果:
- 据估计,发现了61,753例多发性硬化病例,原始患病率为132.0/100,000,年龄标准化率为123.5/100,000.
- 观察到女性与男性的比例为2.0,男性的年龄特异性流行率比女性低.
- 在自治社区中检测到MS患病率的北南梯度很大,北部地区的风险更高,南部地区的风险更低.
结论:
- 本研究提供了西班牙最新的MS流行数据,突出了自治社区层面的显著地理差异.
- 证实了MS患病率的明显南北梯度,这对了解疾病分布有意义.
- 这些发现支持制定有针对性的管理策略,并进一步研究西班牙MS的因果因素.
相关概念视频
Prevalence and Incidence
841
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
841
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
40
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
40
Secondary Healthcare System
1.6K
Secondary healthcare is offered by a specialist, generally in hospitals or clinics for patients referred by primary healthcare providers. It occurs when a person has an illness or injury that requires specific medical care. Secondary care is often referred to as acute care. Secondary care can range from uncomplicated care to repair a minor laceration or treat a strep throat infection to more complicated emergent care, such as treating a head injury sustained in an automobile accident. Whatever...
1.6K
Principles of Disease Surveillance
190
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
190
Clinical Trials
9.3K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
9.3K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K


